Supply Side West 2024 Tradeshow Preview: Meet Our Next Gen NAD+ Booster NMNH & Game-Changing Liposomal Delivery System LipoAvail™
2024-10-29 | EffePharm
Summary
Your Product Innovation Begins Here!
SupplySide West is around the corner, and we're thrilled to give you a peek at our showcase:
📌 UthPeak™ NMNH: World’s first self-GRAS approved NMNH (reduced NMN)
📌 LipoAvail™ Liposomal Technology: Science-validated liposomal technology to increase bioavailability.
Visit 📍 booth 4055 to discover how we can elevate your product offerings. Schedule a meeting with our team and be part of the innovation wave!
Come and visit us at
Booth 4055
Oct 30-31
Las Vegas, United States.
As we prepare for the thrilling SupplySide West (SSW) 2024 tradeshow, the EffePharm team is excited to invite you to embark on a journey of innovation and discovery with us. Save the dates—October 30-31—and be sure to visit us at Booth 4055 in Las Vegas!
This year, we’re unveiling our groundbreaking NAD+ booster, UthPeak™ NMNH (reduced NMN), alongside our cutting-edge liposomal delivery system, LipoAvail™. These two revolutionary products are designed to elevate your health and well-being to new heights.
Healthy-Aging Line
UthPeak™️ NMNH: First Self-GRAS Approved Reduced NMN
Our next-generation NAD+ enhancer, UthPeak™ NMNH, has recently achieved Self-GRAS status, establishing it as a pioneer in the NMNH category. This innovative supplement has undergone rigorous safety validation by scientific committees and is designed to significantly enhance NAD+ levels. Notably, UthPeak™ NMNH can increase NAD+ levels by nearly ten times compared to baseline levels, underscoring its remarkable effectiveness in supporting cellular health.
Following in the footsteps of UTHEVER® NMN, the world’s first NMN, EffePharm is dedicated to delivering clinically validated innovations. Our UthPeak™ NMNH is on a clear clinical path with efficacy tests highlighting its potential benefits in:
ANTI-FATIGUE
SLEEP QUALITY IMPROVEMENT
HEART HEALTH PROTECTION
BRAIN FUNCTION ENHANCEMENT
ANTI-AGING
The upcoming clinical trials for UthPeak™ NMNH will evaluate its potential to enhance well-being factors that matter most to consumers, including cardioprotection, neuroprotection, and liver health. Phase I of the trials is set to conclude in December this year, with Phase II anticipated in October 2025. In addition to these studies, EffePharm remains dedicated to advancing its line of NAD+ enhancers, aiming to provide safer and more effective products that can benefit millions around the globe.
ErgoX™️ Ergothione: Entering the new era of targeted super antioxidant against age
In the dynamic realm of antioxidant technology, ergothioneine is emerging as a captivating player—a rare, naturally occurring sulfur-containing amino acid that has piqued the interest of researchers and health enthusiasts alike. First isolated from the Agaricus bisporus mushroom in 1909, this remarkable compound has since gained recognition for its powerful antioxidant capabilities and its role in cellular protection. Ergothioneine is abundantly found throughout the human body, with particularly high concentrations in vital areas such as red blood cells, the liver, and the kidneys. However, since our bodies cannot produce this essential nutrient on their own, we must rely on our diets to obtain it.
Enter ErgoX™️, a pioneering product that harnesses cutting-edge extraction and purification methods to deliver premium ergothioneine to consumers. This innovative approach not only makes this crucial antioxidant more accessible but also opens the door to a myriad of potential health benefits. With ongoing research highlighting its ability to combat oxidative stress and support various aspects of well-being—from skin health to cognitive function—ergothioneine is poised to become a must-have ingredient in dietary supplements aimed at enhancing vitality and longevity. Discover the power of ergothioneine and elevate your health journey today!
Why ErgoX Ergothioneine
High purity: Purity≥99.5%
Proprietary Enzyme and Fermentation Process: Utilizing advanced cell factory technology, ErgoX™ employs a proprietary enzyme to biosynthesize ergothioneine in a safe, efficient manner, significantly reducing costs.
Excellent Quality: Strictly regulate the content of heavy metals and microorganisms to ensure the product’s safety and high quality.
Better appearance: Pure white powder with uniform particle size and no odor.
Versatile applications: Excellent cold water solubility, stability, and dispersibility, making it easier to incorporate into diverse dietary supplements and cosmetic product formats.
LipoAvail™️ Liposomal Technology: Advanced Liposomal Delivery System
LipoAvail™️ utilizes cutting-edge liposomal encapsulation technology to deliver active ingredients within tiny lipid spheres known as liposomes. These liposomes feature a unique bilayer structure, with a hydrophilic outer layer and a hydrophobic inner layer, closely resembling the membranes of human cells. This innovative design enhances the absorption of encapsulated nutrients and offers five key advantages: improved bioavailability, high encapsulation efficiency, authenticity confirmed by transmission electron microscopy (TEM), nanoscale particle size, and versatility across various dosage forms.
Enhanced bioavailability: Lab-validated bioavailability increment.
High encapsulation rate: Maximized active ingredients delivery.
Electron microscopy imaging: Authenticity of liposomes validated by TEM.
Nanoscale particle size: All below 100nm, ensured through homogenization techniques.
Versatile applications: Excellent stability and dispersibility for easy application and absorption.
LipoAvail™ Liposomes: Authenticity Proven By TEM
Entrapment efficiency, drug loading capacity, nanoparticle size and morphology, formulation process, and various other factors influence the quality and efficacy of liposomal products. LipoAvail™ technology is the result of extensive research and optimization. Advanced electron microscopy confirms the quality and uniformity of our liposomes, ensuring product integrity.
LipoAvail™ liposomes have a more regular spherical morphology.
The active ingredients are encapsulated by phospholipids, resulting in a more uniform particle size distribution.
Unqualified liposomes have irregular shapes, non-spherical morphology, insufficient encapsulation, and poor particle size uniformity.
UthPeak™ NMNH Forum: Healthy Aging with Evidence-Based Supplementation
We invite you to join our scientific advisor, Dr. Richard Kaszynski, co-founder and director of Stanford SOLUTIONS, as he presents the UthPeak™ NMNH Forum. In this session, Dr. Kaszynski will discuss the significant potential of UthPeak™ NMNH in the healthy aging supplement market, highlighting its scientific validation and its focus on mitochondrial health.
Don’t miss this opportunity to learn more! Meet us at SupplySide West at Presentation Theater, Booth 3683, on October 30th from 2:30 to 2:50 p.m. We look forward to seeing you there as we explore the next chapter in anti-aging solutions together!
Visit us at Booth 4055 to check about more
- UthPeak® Reduced NMN (NMNH)
World's First, Largest, and Longest Human Clinical Trial on Reduced NMN (NMNH)Learn more - ErgoX™ Ergothioneine
Targeted Super Antioxidant Against AgeLearn more - Liposomal Glutathione
Glutathione is a key antioxidant composed of three amino acids. It serves as an important metabolic regulator within cells.Learn more
Schedule an Appointment with EffePharm's Experts
Reference available upon request.
| These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.